Argenx announces annual general meeting of shareholders on may 7, 2024

March 26, 2024 amsterdam, the netherlands – argenx se (euronext & nasdaq: argx), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that the annual general meeting of shareholders will be held at 13:00 cet on tuesday, may 7, 2024 at the hilton amsterdam schiphol at schiphol boulevard 701, 1118 bn schiphol, the netherlands. the shareholders and all other persons with meeting rights are invited to attend the annual general meeting of shareholders.
ARGX Ratings Summary
ARGX Quant Ranking